IntelliSyn is formally X-Chem! X-Chem, Inc. is the leader in small molecule discovery science. In unifying the companies’ offerings, X-Chem now provides you a complete, seamless solution for screening, hit validation and lead optimization. Please keep up to date with our latest news and updates — follow the @X-Chem page!
| Website | https://www.x-chemrx.com/ |
| Revenue | $42.3 million |
| Employees | 3 (2 on RocketReach) |
| Founded | 2011 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Small Molecule, Drug Discovery, Medicinal Chemistry, Molecular Discovery, Lead Optimization, Drug Development, Lead Generation, Pharmaceutical Research, Preclinical Development, Hit Identification, Pharma, Compound Library, Life Sciences, Biotechnology, Biopharma, Chemical Synthesis, Chemistry |
| Competitors | Celerion, Medpace, Charles River Laboratories, WuXi AppTec, Parexel, IQVIA, Covance, Worldwide Clinical Trials, Syneos Health, PPD +44 more (view full list) |
Looking for a particular IntelliSyn R&D employee's phone or email?
IntelliSyn R&D Questions
The IntelliSyn R&D annual revenue was $42.3 million in 2026.
2 people are employed at IntelliSyn R&D.
Top IntelliSyn R&D Employees
Related Companies
G2Crowd Trusted
300K+
Plugin Users
